Andreas Zwergal Selected Research

Proteins (Proteins, Gene)

1/2018	Coupling between physiological TSPO expression in brain and myocardium allows stabilization of late-phase cerebral [18F]GE180 PET quantification.
12/2009	C/EBPbeta enhances NF-kappaB-associated signalling by reducing the level of IkappaB-alpha.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andreas Zwergal Research Topics

Disease

4	Vertigo (Positional Vertigo) 10/2021 - 01/2010
3	Dizziness (Lightheadedness) 01/2023 - 02/2020
3	Type 2 Episodic Ataxia 04/2015 - 04/2007
2	Tremor (Tremors) 04/2024 - 01/2017
2	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 01/2019
2	Vestibular Neuronitis (Vestibular Neuritis) 01/2022 - 07/2009
2	Nervous System Diseases (Neurological Disorders) 02/2017 - 04/2007
1	Primary orthostatic tremor 04/2024
1	Neuroinflammatory Diseases 03/2024
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023
1	Parkinson Disease (Parkinson's Disease) 01/2022
1	Cognitive Dysfunction 01/2020
1	Tauopathies 01/2019
1	Motor Disorders 01/2019
1	Brain Diseases (Brain Disorder) 01/2018
1	Ventricular Premature Complexes (Premature Ventricular Contraction) 08/2016
1	Hallucinations (Hallucination) 08/2016
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 08/2016
1	Cerebellar Ataxia (Dysmetria) 04/2015
1	Meniere Disease (Menieres Disease) 04/2015
1	Migraine Disorders (Migraine) 04/2015
1	Cerebellar Diseases (Cerebellar Syndrome) 04/2015
1	Benign Paroxysmal Positional Vertigo 04/2015
1	Body Weight (Weight, Body) 01/2015
1	Alcoholism (Alcohol Abuse) 03/2012
1	Inflammation (Inflammations) 12/2009
1	Atherosclerosis 01/2007
1	Sepsis (Septicemia) 06/2003

Drug/Important Bio-Agent (IBA)

4	AminopyridinesIBA 01/2019 - 07/2009
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 12/2009
2	Potassium Channel Blockers (Blockers, Potassium Channel)IBA 02/2017 - 07/2009
2	4-Aminopyridine (4 Aminopyridine)FDA Link 02/2017 - 04/2015
2	Betahistine (Serc)IBA 04/2015 - 07/2009
2	Carbamazepine (Tegretol)FDA LinkGeneric 04/2015 - 07/2009
2	acetylleucineIBA 04/2015 - 01/2015
2	CCAAT-Enhancer-Binding Protein-betaIBA 12/2009 - 06/2003
1	Histamine (Histamine Dihydrochloride)FDA Link 03/2024
1	Glycoproteins (Glycoprotein)IBA 01/2023
1	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2022
1	Amyloid (Amyloid Fibrils)IBA 01/2020
1	3- (1,3- benzodioxol- 5- yl)- 5- (3- bromophenyl)- 1H- pyrazoleIBA 01/2019
1	ConvulsantsIBA 01/2019
1	AmifampridineIBA 02/2017
1	Glucose (Dextrose)FDA LinkGeneric 01/2017
1	rasagiline (Azilect)FDA Link 08/2016
1	Antidepressive Agents (Antidepressants)IBA 04/2015
1	Metoprolol (Toprol-XL)FDA LinkGeneric 04/2015
1	AntiemeticsIBA 04/2015
1	Anticonvulsants (Antiepileptic Drugs)IBA 04/2015
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 04/2015
1	Vitamin D FDA LinkGeneric 04/2015
1	Acetazolamide (Diamox)FDA LinkGeneric 04/2015
1	PlacebosIBA 01/2015
1	Leucine (L-Leucine)FDA Link 01/2015
1	Dopamine (Intropin)FDA LinkGeneric 03/2012
1	RacloprideIBA 03/2012
1	NF-kappa B (NF-kB)IBA 12/2009
1	oxcarbamazepineIBA 07/2009
1	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2009
1	Calcium Channels (Calcium Channel)IBA 04/2007
1	oxidized low density lipoproteinIBA 01/2007
1	Interleukin-8 (Interleukin 8)IBA 06/2003

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 01/2019 - 01/2010
2	Therapeutics 10/2021 - 01/2019
1	Transcranial Magnetic Stimulation 04/2024
1	Activities of Daily Living (ADL) 01/2023
1	Physical Therapy Modalities (Physical Therapy Technique) 01/2023
1	Deep Brain Stimulation 01/2022
1	Combined Modality Therapy 02/2020
1	Occupational Therapy (Therapy, Occupational) 02/2020